Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
3(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
4
44%
Ph phase_1
4
44%
Ph early_phase_1
1
11%

Phase Distribution

5

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 1Safety & dosage
4(44.4%)
Phase 2Efficacy & side effects
4(44.4%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(8)
Completed(1)

Detailed Status

Not yet recruiting5
Recruiting3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (11.1%)
Phase 14 (44.4%)
Phase 24 (44.4%)

Trials by Status

completed111%
not_yet_recruiting556%
recruiting333%

Recent Activity

3 active trials
Showing 5 of 9
not_yet_recruitingphase_1

A Study of Psychedelics in Healthy Older Adults With Low Well-being

NCT07386730
not_yet_recruitingphase_2

Group PACBT for Depression

NCT07566104
not_yet_recruitingphase_2

NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy

NCT07227909
not_yet_recruitingphase_1

The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers.

NCT07433452
recruitingphase_1

RCT of Psilocybin-assisted CBT for Depression

NCT07281352
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07386730Phase 1

A Study of Psychedelics in Healthy Older Adults With Low Well-being

Not Yet Recruiting
NCT07566104Phase 2

Group PACBT for Depression

Not Yet Recruiting
NCT07227909Phase 2

NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy

Not Yet Recruiting
NCT07433452Phase 1

The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers.

Not Yet Recruiting
NCT07281352Phase 1

RCT of Psilocybin-assisted CBT for Depression

Recruiting
NCT07183748Phase 2

Psilocybin Microdosing With Psychotherapy for Treatment-Resistant Depression

Recruiting
NCT07118332Early Phase 1

Psilocybin as a Treatment for Chronic Pain in Smokers

Not Yet Recruiting
NCT06969170Phase 2

Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder

Recruiting
NCT00302744Phase 1

Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9